Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome

被引:117
作者
Glaser, RL
Jiang, W
Boyadjiev, SA
Tran, AK
Zachary, AA
Van Maldergem, L
Johnson, M
Walsh, S
Oldridge, M
Wall, SA
Wilkie, AOM
Jabs, EW
机构
[1] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Dept Med, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Ctr Craniofacial Dev & Disorders, Dept Pediat, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Ctr Craniofacial Dev & Disorders, Dept Plast Surg, Baltimore, MD USA
[4] Univ Maryland, Baltimore Coll Dent Surg, Dept Orthodont, Baltimore, MD 21201 USA
[5] Ctr Genet Med, Inst Pathol & Genet, Loverval, Belgium
[6] John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DU, England
[7] Radcliffe Infirm, Oxford Craniofacial Unit, Oxford OX2 6HE, England
关键词
D O I
10.1086/302831
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Crouzon syndrome and Pfeiffer syndrome are both autosomal dominant craniosynostotic disorders that can be caused by mutations in the fibroblast growth factor receptor 2 (FGFR2) gene. To determine the parental origin of these FGFR2 mutations, the amplification refractory mutation system (ARMS) was used, ARMS IS PCR primers were developed to recognize polymorphisms that could distinguish maternal and paternal alleles, A total of 4,374 bases between introns IIIa and 11 of the FGFR2 gene were sequenced and were assayed by heteroduplex analysis, to identify polymorphisms. Two polymorphisms (1333TA/TATA and 2710 C/T) were found and were used with two previously described polymorphisms, to screen a total of 41 families, Twenty-two of these families were shown to be informative (11 for Crouzon syndrome and 11 for Pfeiffer syndrome), Eleven different mutations in the 22 families mere detected by either restriction digest or allele-specific oligonucleotide hybridization of ARMS PCR products. We molecularly proved the origin of these different mutations to be paternal for all informative cases analyzed (P = 2.4 x 10(-7); 95% confidence limits 87%-100%). Advanced paternal age was noted for the fathers of patients with Crouzon syndrome or Pfeiffer syndrome, compared with the fathers of control individuals (34.50 +/- 7.65 years vs. 30.45 +/- 1.28 years, P < .01), Our data on advanced paternal age corroborates and extends previous clinical evidence based on statistical analyses as well as additional reports of advanced paternal age associated with paternal origin of three sporadic mutations causing Apert syndrome (FGFR2) and achondroplasia (FGFR3). Our results suggest that older men either have accumulated or are more susceptible to a variety of germline mutations.
引用
收藏
页码:768 / 777
页数:10
相关论文
共 41 条